Charles Mackworth‐Young

1.0k total citations
30 papers, 660 citations indexed

About

Charles Mackworth‐Young is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Charles Mackworth‐Young has authored 30 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Rheumatology, 11 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Immunology. Recurrent topics in Charles Mackworth‐Young's work include Systemic Lupus Erythematosus Research (13 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Platelet Disorders and Treatments (5 papers). Charles Mackworth‐Young is often cited by papers focused on Systemic Lupus Erythematosus Research (13 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Platelet Disorders and Treatments (5 papers). Charles Mackworth‐Young collaborates with scholars based in United Kingdom, United States and Denmark. Charles Mackworth‐Young's co-authors include Mark Walport, G D Ross, James Watson, P. J. Lachmann, Nancy Hogg, G. R. V. Hughes, A E Gharavi, S. Loizou, Christopher Bunn and K P McAdam and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Journal of Hepatology.

In The Last Decade

Charles Mackworth‐Young

28 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Mackworth‐Young United Kingdom 13 379 279 242 183 76 30 660
Haraldine A. Stafford United States 12 305 0.8× 327 1.2× 218 0.9× 117 0.6× 63 0.8× 22 578
Erica van Oort Netherlands 14 395 1.0× 185 0.7× 136 0.6× 288 1.6× 90 1.2× 17 827
Pamela V. Taylor United Kingdom 9 455 1.2× 355 1.3× 199 0.8× 85 0.5× 50 0.7× 13 912
J. Simón Mexico 14 412 1.1× 248 0.9× 105 0.4× 116 0.6× 36 0.5× 23 667
Y C Ng United Kingdom 11 197 0.5× 491 1.8× 132 0.5× 273 1.5× 79 1.0× 13 726
Gale A. McCarty United States 13 410 1.1× 248 0.9× 137 0.6× 102 0.6× 93 1.2× 21 725
Yufeng Yin China 16 364 1.0× 279 1.0× 86 0.4× 186 1.0× 150 2.0× 37 811
Junko Moriuchi Japan 16 175 0.5× 360 1.3× 174 0.7× 79 0.4× 74 1.0× 55 729
Rosemarie M. Watson United States 14 438 1.2× 315 1.1× 159 0.7× 50 0.3× 77 1.0× 16 902
A. Lamour France 16 257 0.7× 308 1.1× 144 0.6× 66 0.4× 118 1.6× 31 642

Countries citing papers authored by Charles Mackworth‐Young

Since Specialization
Citations

This map shows the geographic impact of Charles Mackworth‐Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Mackworth‐Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Mackworth‐Young more than expected).

Fields of papers citing papers by Charles Mackworth‐Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Mackworth‐Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Mackworth‐Young. The network helps show where Charles Mackworth‐Young may publish in the future.

Co-authorship network of co-authors of Charles Mackworth‐Young

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Mackworth‐Young. A scholar is included among the top collaborators of Charles Mackworth‐Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Mackworth‐Young. Charles Mackworth‐Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tincani, Anǵela, et al.. (2023). The history of antiphospholipid syndrome. SHILAP Revista de lepidopterología. 74(4). 5 indexed citations
2.
Marian, Ioana R., Jennifer A. E. Williams, Anne Francis, et al.. (2021). Hand Osteoarthritis: investigating Pain Effects of estrogen-containing therapy (HOPE-e): a protocol for a feasibility randomised placebo-controlled trial. Pilot and Feasibility Studies. 7(1). 133–133.
3.
Steele, Lloyd, Katie Bechman, Eoghan de Barra, & Charles Mackworth‐Young. (2017). Meningococcal arthritis and myopericarditis: a case report. BMC Infectious Diseases. 17(1). 751–751. 7 indexed citations
4.
Farah, Ziad, et al.. (2016). Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years. Biologics. 10. 59–59. 5 indexed citations
5.
Mackworth‐Young, Charles, et al.. (2015). Antiphospholipid antibodies as biomarkers in psychiatry: review of psychiatric manifestations in antiphospholipid syndrome. 3(1). 25452–25452. 11 indexed citations
7.
Hunnangkul, Saowalak, Dorothea Nitsch, Benjamin Rhodes, et al.. (2008). Familial clustering of non‐nuclear autoantibodies and C3 and C4 complement components in systemic lupus erythematosus. Arthritis & Rheumatism. 58(4). 1116–1124. 11 indexed citations
9.
Mageed, Rizgar A., et al.. (2001). The effects of a human IgM monoclonal anticardiolipin antibody on pregnancy in a transgenic mouse model. Lupus. 10(4). 289–294. 4 indexed citations
10.
Mackworth‐Young, Charles. (2000). Treatment of Osteoarthritis by Cutaneous Injection of Salicylate or Saline: A Pilot Study. 22(3). 75–80. 3 indexed citations
11.
Mageed, Rizgar A., et al.. (1999). The BH1 idiotype defines a population of anticardiolipin antibodies closely associated with the antiphospholipid syndrome. Lupus. 8(3). 234–239. 3 indexed citations
12.
Mackworth‐Young, Charles, Felicita Andreotti, S. Loizou, et al.. (1995). ENDOTHELIUM-DERIVED HAEMOSTATIC FACTORS AND THE ANTIPHOSPHOLIPID SYNDROME. Lara D. Veeken. 34(3). 201–206. 14 indexed citations
13.
Mackworth‐Young, Charles. (1995). The Michael Mason Prize Essay (1994) ANTIPHOSPHOLIPID ANTIBODIES AND DISEASE. Lara D. Veeken. 34(11). 1009–1030. 10 indexed citations
14.
Loizou, S., et al.. (1995). A human monoclonal antiphospholipid antibody that is representative of serum antibodies and is germline encoded. Arthritis & Rheumatism. 38(8). 1068–1076. 25 indexed citations
15.
Duggan, David B., et al.. (1988). Polyspecificity of human monoclonal antibodies reactive with Mycobacterium leprae, mitochondria, ssDNA, cytoskeletal proteins, and the acetylcholine receptor. Clinical Immunology and Immunopathology. 49(3). 327–340. 26 indexed citations
16.
Mackworth‐Young, Charles & Schwartz Rs. (1988). Autoantibodies to DNA.. PubMed. 8(3). 147–73. 27 indexed citations
17.
Harris, E. Nigel, A E Gharavi, S. Loizou, et al.. (1985). Crossreactivity of antiphospholipid antibodies.. PubMed. 16(1). 1–6. 114 indexed citations
18.
Bernstein, Robert M., et al.. (1984). Yersinia arthritis: demonstration of occult enteritis by 111indium leucocyte scanning.. Annals of the Rheumatic Diseases. 43(3). 493–494. 4 indexed citations
19.
Mackworth‐Young, Charles, et al.. (1984). Intravenous Methylprednisolone in the Treatment of Systemic Lupus Erythematosus. Scandinavian Journal of Rheumatology. 13(sup54). 16–18. 1 indexed citations
20.
Mackworth‐Young, Charles. (1983). Sequential Musical Symptoms in a Professional Musician with Presumed Encephalitis. Cortex. 19(3). 413–419. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026